Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Ordinary Shares, nominal value GBP0.05 per share
-
Shares outstanding
-
84.8M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
115K
-
Shares change
-
+83.2K
-
Total reported value, excl. options
-
$2.28M
-
Value change
-
+$1.65M
-
Number of buys
-
2
-
Price
-
$19.88
Significant Holders of Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA) as of Q4 2023
3 filings reported holding VRNA - Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share as of Q4 2023.
Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 115K shares
of 84.8M outstanding shares and own 0.14% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6.32M shares), NEA Management Company, LLC (5.11M shares), FMR LLC (4.9M shares), Vivo Capital, LLC (4.25M shares), PERCEPTIVE ADVISORS LLC (3.87M shares), WELLINGTON MANAGEMENT GROUP LLP (3.78M shares), ORBIMED ADVISORS LLC (3.78M shares), Deep Track Capital, LP (3.19M shares), Frazier Life Sciences Management, L.P. (3.01M shares), and FEDERATED HERMES, INC. (2.49M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.